您的位置: 首页 > 农业专利 > 详情页

COMPOSÉ BICYCLIQUE CONTENANT DU SOUFRE
专利权人:
Astellas Pharma Inc.
发明人:
申请号:
EP14853825.9
公开号:
EP3059239A1
申请日:
2014.10.17
申请国别(地区):
EP
年份:
2016
代理人:
摘要:
[Problem] Provided is a compound which is useful as a pharmaceutical composition for preventing and/or treating schizophrenia, cognitive impairment associated with schizophrenia (CIAS), cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, Charcot-Marie-Tooth disease, or the like.[Means for Solution] The present inventors have studied that a pharmaceutical composition for preventing and/or treating schizophrenia, cognitive impairment associated with schizophrenia (CIAS), cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, Charcot-Marie-Tooth disease, or the like, which has a positive allosteric modulator (PAM action) of GABAB, and have found that a sulfur-containing bicyclic compound is a PAM of a GABAB receptor, thereby completing the present invention. The sulfur-containing bicyclic compound of the present invention has a PAM action of GABAB, and can be used as an agent for preventing and/or treating schizophrenia, CIAS, cognitive impairment, fragile X syndrome, autism spectrum disorder, spasticity, anxiety disorder, substance addiction, pain, fibromyalgia, or Charcot-Marie-Tooth disease.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充